$PLSE Cashflow Statement | Understand Stock

$PLSE

$53.20 +$0.54 (1.03%) Close

$PLSE Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation
Amortization of intangible assets
Stock-based compensation
Write-off of excessive and obsolete inventory
Net premium amortization and discount on available-for-sale securities
Non-cash lease expense
Loss on disposal of fixed assets
Gain on U.S. Treasury securities

Changes in operating assets and liabilities:
Accounts receivable
Inventory
Prepaid expenses and other current assets
Other receivables
Right-of-use assets
Other non-current assets
Accounts payable
Accrued liabilities
Lease liabilities
Deferred revenue
Lease liabilities, net
Accrued interest on related party note payable
Accrued interest on note payable
Net cash used in operating activities

Cash flows from investing activities:
Purchases of property and equipment
Purchases of investments
Maturities of investments
Sales of investments
Purchases of intangible assets
Net cash used in investing activities

Cash flows from financing activities:
Proceeds from issuance of common stock under employee stock purchase plan
Proceeds from exercises of warrants, net of issuance costs
Proceeds from exercises of stock options
Proceeds from issuance of common stock
Proceeds from issuance of related party note
Proceeds from insurance loan agreement
Proceeds from issuance of common stock and warrants in relation to rights offering, net of issuance costs
Issuance cost in relation to related party note extinguishment
Payments made on insurance loan agreement
Tax payments related to shares withheld for vested restricted stock units
Payment of deferred issuance costs in relation to at-the-market equity offering program
Net cash provided by financing activities

Net increase (decrease) in cash and cash equivalents
Net (decrease) increase in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental disclosure of noncash investing and financing activities:
Proceeds from exercise of warrants and stock options not yet received
Change in unrealized gains on available-for-sale securities
Unpaid warrant issuance costs
Unpaid amounts related to purchase of equipment
Rights offering deemed pro-rata distribution to shareholders
Principal and accrued interest of related party note settled via issuance of common stock
Right-of-use asset obtained in exchange for lease liability
Other receivable from exercise of warrants
Equipment purchases included in accounts payable and accrued expenses
Rights offering and warrant issuance costs in accounts payable and accrued expenses

Comments